Forte Biosciences, Inc. (FBRX) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Forte Biosciences, Inc. (FBRX).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $10.30

Daily Change: -$0.28 / 2.72%

Daily Range: $9.95 - $10.64

Market Cap: $125,802,144

Daily Volume: 127,288

Performance Metrics

1 Week: 3.21%

1 Month: -17.47%

3 Months: 66.40%

6 Months: -31.33%

1 Year: -17.67%

YTD: -54.65%

Company Details

Employees: 14

Sector: Health technology

Industry: Biotechnology

Country:

Details

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Selected stocks

Pimco Global StocksPlus & Income Fund (PGP)

Starwood Property Trust Inc. (STWD)

Delek Logistics Partners, L.P. (DKL)